hepatitis c

(University of Illinois at Chicago) A molecule embedded in the membrane of human liver cells that aids in cholesterol absorption also allows the entry of hepatitis C virus, the first step in hepatitis C infection, according to research at the University of Illinois at Chicago College of Medicine.

(MedPage Today) -- A combination of direct-acting antiviral agents aimed at hepatitis C -- and given without standard therapy -- can lead to sustained virologic response in patients with a difficult-to-treat strain of the virus.

(University of British Columbia) Researchers at the University of British Columbia have found a new way to block infection from the hepatitis C virus in the liver that could lead to new therapies for those affected by this and other infectious diseases.

An early clinical trial of a hepatitis C vaccine has shown "promising" results, according to researchers at Oxford University.

(MedPage Today) -- Screening patients for hepatitis C virus based on their age rather than their risk was cost-effective, researchers found.

(MedPage Today) -- Human error led to at least one person being infected with hepatitis C after a cardiopulmonary patch transplant, the CDC reported.

(Emory University) Chronic infections by viruses such as HIV or hepatitis C eventually take hold because they wear the immune system out, a phenomenon immunologists describe as exhaustion.

Yet exhausted immune cells can be revived after the introduction of fresh cells that act like coaches giving a pep talk, researchers at Emory Vaccine Center have found.

Dirty needles at a private clinic have been blamed for an outbreak of hepatitis C among kids in central China, underscoring the challenges of policing healthcare as clinics mushroom to meet growing demand.

(University of Liverpool) The University of Liverpool has launched an iphone app, HEP i-chart, that provides Hepatitis C patients with quick and easy access to the latest information about drug interactions.

SAN FRANCISCO (MedPage Today) -- A botanical agent used in the treatment of liver disorders had no detectable effect on hepatitis C virus disease activity in comparison with placebo in patients with previously treated chronic disease, results of a randomized trial showed.